Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation)
Atlas Antibodies
- SKU:
- ATL-HPA055889-25
- Shipping:
- Calculated at Checkout
$395.00
Gene Name: NFE2L3
Alternative Gene Name: Nrf3
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000029832: 67%, ENSRNOG00000010886: 58%
Entrez Gene ID: 9603
Uniprot ID: Q9Y4A8
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Product Specifications | |
Application | ICC, IHC |
Reactivity | Human |
Clonality | Polyclonal |
Host | Rabbit |
Immunogen | LEGISLGDIPLPGSISDGMNSSAHYHVNFSQAISQDVNLHEAILLCPNNTFRRDPTARTSQSQEPFLQLNSHTTNPEQTLPGTNLTGFLSPVDNHMRNLTSQDLLYD |
Gene Sequence | LEGISLGDIPLPGSISDGMNSSAHYHVNFSQAISQDVNLHEAILLCPNNTFRRDPTARTSQSQEPFLQLNSHTTNPEQTLPGTNLTGFLSPVDNHMRNLTSQDLLYD |
Gene ID - Mouse | ENSMUSG00000029832 |
Gene ID - Rat | ENSRNOG00000010886 |
Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
Documents & Links for Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) | |
Datasheet | Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) at Atlas Antibodies |
Documents & Links for Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) | |
Datasheet | Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) |
Citations for Anti NFE2L3 pAb (ATL-HPA055889 w/enhanced validation) – 5 Found |
Wang, Chaojie; Saji, Motoyasu; Justiniano, Steven E; Yusof, Adlina Mohd; Zhang, Xiaoli; Yu, Lianbo; Fernández, Soledad; Wakely, Paul Jr; La Perle, Krista; Nakanishi, Hiroshi; Pohlman, Neal; Ringel, Matthew D. RCAN1-4 is a thyroid cancer growth and metastasis suppressor. Jci Insight. 2017;2(5):e90651. PubMed |
Dai, Yue-Chu; Pan, Yin; Quan, Ming-Ming; Chen, Qi; Pan, Yue; Ruan, Yan-Yun; Sun, Jian-Guo. MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3. Frontiers In Oncology. 11( 34926237):677168. PubMed |
Immonen, Anni; Haapasaari, Kirsi-Maria; Skarp, Sini; Karihtala, Peeter; Teppo, Hanna-Riikka. NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma. Oxidative Medicine And Cellular Longevity. 2022( 35378827):2240223. PubMed |
Wang, Hui; Zhan, Ming; Yang, Ruimeng; Shi, Yongheng; Liu, Qiang; Wang, Jian. Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients. Cell Cycle (Georgetown, Tex.). 17(17):2164-2174. PubMed |
Kobayashi, Akira. Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors. Cancers. 2020;12(9) PubMed |